Related references
Note: Only part of the references are listed.Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal
L. Daelman et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
SEVERE MULTIPLE SCLEROSIS RELAPSE UNDER FINGOLIMOD THERAPY: INCIDENT OR COINCIDENCE?
F. Castrop et al.
NEUROLOGY (2012)
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
M. C. Kowarik et al.
NEUROLOGY (2011)
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
M. Mehling et al.
NEUROLOGY (2010)
Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis
K. Yanagawa et al.
NEUROLOGY (2009)
Autoimmune T cell responses in the central nervous system
Joan Goverman
NATURE REVIEWS IMMUNOLOGY (2009)
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2008)
Oral fingolimod (FTY720) for relapsing multiple sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Expression of CCR7 in multiple sclerosis:: Implications for CNS immunity
P Kivisäkk et al.
ANNALS OF NEUROLOGY (2004)
Share Paper
